Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease
Condition: Non-alcoholic Fatty Liver Disease (NAFLD) Interventions: Drug: Metabolic Cofactor Supplementation; Drug: Sorbitol Sponsors: ScandiBio Therapeutics AB; Koç University; Koç University Hospital; Göteborg University; Sahlgrenska University Hospital, Sweden; KTH Royal Institute of Technology; University of Helsinki; Helsinki University Central Hospital; Monitor CRO Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials